LDN is known to temporarily inhibit the binding of Opioid Growth Factor (OGF)—a peptide that regulates cell proliferation—to its receptor (OGFr). This modulation is hypothesized to be a factor in LDN’s potential anti-inflammatory and anti-proliferative effects, particularly in autoimmune and cancer contexts.